Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Medical Oncology
•
Hematology
•
Sickle Cell
•
Pediatric Hematology
•
Primary Care
What is your target Hgb/Hct for women who are pregnant and have sickle cell disease in whom you are doing scheduled transfusions?
Answer from: at Academic Institution
Assuming that the patient is truly transfusion-dependent, the usual target range is a Hb of 9.5-10.5.
Sign In
or
Register
to read more
Answer from: at Community Practice
Hg 10-11. My main goal is to suppress reticulocytosis and therefore, the production of more sickled cells.
Sign In
or
Register
to read more
21519
21802
Related Questions
What is your approach to screening a cancer survivor for iron overload, and what is your treatment of choice?
What are your top takeaways from ISTH 2025?
What is your approach to IV fluid resuscitation during a sickle cell vaso-occlusive crisis?
What are your top takeaways in Classical Hematology from ASH 2024?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
In an adult patient with asymptomatic, isolated neutropenia in whom you suspect a Duffy null phenotype, at what ANC or in what situations would you do a bone marrow to look for other etiologies of neutropenia?
In pure red cell aplasia, does peripheral blood-positive IgG for parvovirus have significance if persistently positive on retesting, but IgM and PCR are negative?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
Given the data from SWOG 1826 suggesting that Nivo-AVD is likely the preferred regimen for advanced Hodgkin lymphoma patients, are there scenarios where alternative regimens may still be preferred?